Matt Zuga - CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO & Chief Business Officer
Issuer Symbol
ABOS on Nasdaq
All Insider Reports
All Insider Reports

Matt Zuga - trading volume in the past year for Acumen Pharmaceuticals, Inc.

Holdings reported by Matt Zuga for Acumen Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 304,924 $567,158 $1.86 22 Jan 2026 Direct
Employee Stock Option (right to buy) 148,700 16 Jan 2026 Direct Common Stock

Transactions reported by Matt Zuga for Acumen Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.